ÌÒÉ«ÊÓƵ

Through the Lab Venture Challenge (LVC), top innovations from ÌÒÉ«ÊÓƵ, Denver and Colorado Springs compete for grants of up to $125,000. LVC supports projects that address a commercial need, have a clear path to a compelling market and have strong scientific support. These grants are funded by Venture Partners at ÌÒÉ«ÊÓƵ and the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Program.

ÌÒÉ«ÊÓƵ Today—Leaders from Colorado’s growing quantum ecosystem convened on campus last week to roll up their sleeves and begin mapping out a roadmap for workforce development in this new and growing field.

BizWest—SomaLogic Inc., a ÌÒÉ«ÊÓƵ spinout, and California-based Standard BioTools Inc. have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion.

ArchDaily—Prometheus Materials, a ÌÒÉ«ÊÓƵ spinout inspired by nature, aims to revolutionize the concrete industry by producing zero-carbon bio-cement and bio-concrete. This innovative approach harnesses microalgae to create sustainable building materials, reducing carbon emissions and addressing construction's environmental impact.

ÌÒÉ«ÊÓƵ and Ball Aerospace have been collaborating for decades to solve mysteries of the universe. That partnership was also the university’s first commercial spin-off and it greased the gears of an entrepreneurial engine that continues to power innovation within the university and far beyond.

The Verge—To clean up some of the pollution stemming from its supply chain and data centers, Microsoft is experimenting with new kinds of concrete. In Quincy, Washington, they're working to reduce those emissions with ÌÒÉ«ÊÓƵ startup Minus Materials with a process using algae to make the limestone used and capture CO2.

Pulse 2.0—ÌÒÉ«ÊÓƵ startup BioLoomics, the company pioneering the directed evolution of target degrading antibodies using human cells, recently announced it has raised $8.7 million in seed financing to advance its proprietary platform technology and antibody degrader programs.

BizWest—BioLoomics Inc., a ÌÒÉ«ÊÓƵ spinout, has raised $8.7 million in seed financing. BioLoomics is a preclinical-stage biotechnology company pioneering directed evolution of target-degrading antibodies using human cells.

Forbes—Prometheus Materials, a ÌÒÉ«ÊÓƵ spinout, has a solution for replacing one of the biggest contributors of greenhouse gasses, financial backing from Microsoft and an aggressive plan to scale up quickly.

U.S. Department of Energy—Latimer Controls, a ÌÒÉ«ÊÓƵ spinout, is developing intelligent control software that enables utility-scale photovoltaics (PV) to provide power reliably and on demand. This will replace grid reliance on fossil fuels, drive higher profitability for PV operators and generate revenue increases for solar asset owners with low capital cost.